increased nuclear nad biosynthesis sirt1 activation prevent axonal degeneration
axonal degeneration active program self-destruction observed many physiological pathological settings wallerian degeneration slow wlds mice wallerian degeneration response axonal injury delayed mutation results overexpression chimeric protein wlds composed ubiquitin assembly protein ufd2a nicotinamide adenine dinucleotide nad biosynthetic enzyme nmnat1 demonstrate increased nmnat activity responsible axon-sparing activity wlds protein furthermore demonstrate sirt1 mammalian ortholog sir2 downstream effector increased nmnat activity leads axonal protection findings suggest novel therapeutic strategies directed increasing supply nad and/or sir2 activation may effective treatment diseases characterized axonopathy neurodegeneration
